Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
HIV Clinical Trials|December 1, 2012
Design and implementation of a randomized crossover study of valproic acid and antiretroviral therapy to reduce the HIV reservoirJ P Routy, J B Angel, J N Spaans, et al.
HIV Medicine|January 27, 2012
Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical studyJ P Routy, C L Tremblay, J B Angel, et al.
AIDS (London, England)|March 9, 2000
Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection StudyH Salomon, M A Wainberg, B Brenner, et al.
HIV Medicine|July 14, 2005
Influence of RANTES, SDF-1 and TGF-beta levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapyM R Boulassel, G H R Smith, M D de B Edwardes, et al.
AIDS Research and Human Retroviruses|July 20, 2001
Improvement of HIV-specific immunity in HIV-infected twins treated with highly active antiretroviral therapy, interleukin 2, and syngeneic adoptively transferred cellsC M Tsoukas, H M Turner, G E Hatzakis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infectionG Alter, G Hatzakis, C M Tsoukas, et al.
The New England Journal of Medicine|October 16, 2009
Interleukin-2 therapy in patients with HIV infection, , D Abrams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2012
Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter studyY Lévy, I Sereti, G Tambussi, et al.
HIV Medicine|January 9, 2019
Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional studyC T Costiniuk, R Nitulescu, Z Saneei, et al.
Pageof 4